VEXAS syndrome

135Citations
Citations of this article
147Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a monogenic disease of adulthood caused by somatic mutations in UBA1 in hematopoietic progenitor cells. Patients develop inflammatory and hematologic symptoms. Myeloid-driven autoinflammation and progressive bone marrow failure lead to substantial morbidity and mortality. Effective medical treatments need to be identified. Reports in the current issue of Blood describe novel UBA1 genetic variants, treatment options, and insight into disease pathophysiology. VEXAS syndrome represents a prototype for a new class of diseases.

Cite

CITATION STYLE

APA

Grayson, P. C., Patel, B. A., & Young, N. S. (2021). VEXAS syndrome. Blood, 137(26), 3591–3594. https://doi.org/10.1182/blood.2021011455

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free